End-to-End Analytical Solutions for mRNA Therapeutics
The AMM and USP workshop End-to-End Analytical Solutions for mRNA Therapeutics will bring together RNA therapeutic industry leaders to discuss how analytics throughout the drug development process can impact mRNA therapeutic development. At the workshop, Eclipsebio’s Wayne Doyle will present on how the sequencing-based analytics in the eMERGE platform provide manufacturing and quality control insights.Interested in how Eclipsebio can help you make RNA insights through sequencing? Contact us today to learn more.
Summary
Dates:
April 14-15, 2026
Location:
Rockville, MD
Topics:
Sequencing based-analytics